5-amino-1mq human trial | NNMT Inhibitor Purity ≥98% 5-Amino-1MQ Research Compound | >99%

Injections ensure you receive the full dose

In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise

AOD 9604 is a synthetically created peptide that works similarly to natural human growth hormones

Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under FFS as of January 2026 (Figure 1)

Experts recommend taking 2.4 micrograms of vitamin B-12 each day